$FGEN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in FIBROGEN INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in FIBROGEN INC. Get notifications about new insider transactions in FIBROGEN INC for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 14 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 63.97 | 120 | 7,676 | 108,564 | 108.7 K to 108.6 K (-0.11 %) |
| Jun 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 63.55 | 798 | 50,713 | 108,684 | 109.5 K to 108.7 K (-0.73 %) |
| Jun 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 63.79 | 11,199 | 714,384 | 2,837,453 | 2.8 M to 2.8 M (-0.39 %) |
| Jun 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 63.31 | 7,701 | 487,550 | 2,848,652 | 2.9 M to 2.8 M (-0.27 %) |
| Jun 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,856,353 | 2.8 M to 2.9 M (+0.36 %) |
| Jun 20 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Option Exercise | M | 2.90 | 4,000 | 11,600 | 0 | |
| Jun 20 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 58.19 | 4,000 | 232,760 | 23,700 | 27.7 K to 23.7 K (-14.44 %) |
| Jun 20 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Buy | M | 2.90 | 4,000 | 11,600 | 27,700 | 23.7 K to 27.7 K (+16.88 %) |
| Jun 15 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Sell | S | 59.20 | 3,422 | 202,582 | 147,469 | 150.9 K to 147.5 K (-2.27 %) |
| Jun 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Option Exercise | M | 25.40 | 7,750 | 196,850 | 50,250 | |
| Jun 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Sell | S | 60.00 | 7,750 | 465,000 | 224,704 | 232.5 K to 224.7 K (-3.33 %) |
| Jun 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Buy | M | 25.40 | 7,750 | 196,850 | 232,454 | 224.7 K to 232.5 K (+3.45 %) |
| Jun 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Sell | S | 57.70 | 2,319 | 133,806 | 224,704 | 227 K to 224.7 K (-1.02 %) |
| Jun 12 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Option Exercise | M | 9.78 | 6,000 | 58,650 | 0 | |
| Jun 12 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Sell | S | 57.48 | 6,000 | 344,880 | 131,540 | 137.5 K to 131.5 K (-4.36 %) |
| Jun 12 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Buy | M | 9.78 | 6,000 | 58,650 | 137,540 | 131.5 K to 137.5 K (+4.56 %) |
| Jun 08 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Payment of Exercise | F | 56.60 | 2,369 | 134,085 | 150,891 | 153.3 K to 150.9 K (-1.55 %) |
| Jun 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Payment of Exercise | F | 56.60 | 6,373 | 360,712 | 2,846,033 | 2.9 M to 2.8 M (-0.22 %) |
| Jun 08 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Sell | S | 55.55 | 1,011 | 56,161 | 227,023 | 228 K to 227 K (-0.44 %) |
| Jun 08 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Payment of Exercise | F | 56.60 | 2,277 | 128,878 | 228,034 | 230.3 K to 228 K (-0.99 %) |
| Jun 07 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Option Exercise | A | 55.30 | 6,000 | 331,800 | 6,000 | |
| Jun 07 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Grant | A | 0.00 | 3,700 | 0 | 51,700 | 48 K to 51.7 K (+7.71 %) |
| Jun 07 2018 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Option Exercise | A | 55.30 | 6,000 | 331,800 | 6,000 | |
| Jun 07 2018 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Grant | A | 0.00 | 3,700 | 0 | 3,700 | 0 to 3.7 K |
| Jun 07 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Option Exercise | A | 55.30 | 6,000 | 331,800 | 6,000 | |
| Jun 07 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Grant | A | 0.00 | 3,700 | 0 | 131,540 | 127.8 K to 131.5 K (+2.89 %) |
| Jun 07 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Option Exercise | A | 55.30 | 6,000 | 331,800 | 6,000 | |
| Jun 07 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Grant | A | 0.00 | 3,700 | 0 | 32,700 | 29 K to 32.7 K (+12.76 %) |
| Jun 07 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Option Exercise | A | 55.30 | 6,000 | 331,800 | 6,000 | |
| Jun 07 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Grant | A | 0.00 | 3,700 | 0 | 382,900 | 379.2 K to 382.9 K (+0.98 %) |
| Jun 07 2018 | FGEN | FIBROGEN INC | Lema Gerald | Director | Option Exercise | A | 55.30 | 6,000 | 331,800 | 6,000 | |
| Jun 07 2018 | FGEN | FIBROGEN INC | Lema Gerald | Director | Grant | A | 0.00 | 3,700 | 0 | 7,200 | 3.5 K to 7.2 K (+105.71 %) |
| Jun 07 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Option Exercise | A | 55.30 | 6,000 | 331,800 | 6,000 | |
| Jun 07 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Grant | A | 0.00 | 3,700 | 0 | 23,700 | 20 K to 23.7 K (+18.50 %) |
| Jun 07 2018 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Option Exercise | A | 55.30 | 6,000 | 331,800 | 6,000 | |
| Jun 07 2018 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Grant | A | 0.00 | 3,700 | 0 | 138,764 | 135.1 K to 138.8 K (+2.74 %) |
| Jun 07 2018 | FGEN | FIBROGEN INC | Henderson Jeffrey William | Director | Option Exercise | A | 55.30 | 6,000 | 331,800 | 6,000 | |
| Jun 07 2018 | FGEN | FIBROGEN INC | Henderson Jeffrey William | Director | Grant | A | 0.00 | 3,700 | 0 | 3,700 | 0 to 3.7 K |
| Jun 07 2018 | FGEN | FIBROGEN INC | EDWARDS JEFFREY L | Director | Option Exercise | A | 55.30 | 6,000 | 331,800 | 6,000 | |
| Jun 07 2018 | FGEN | FIBROGEN INC | EDWARDS JEFFREY L | Director | Grant | A | 0.00 | 3,700 | 0 | 3,700 | 0 to 3.7 K |
| Jun 05 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Payment of Exercise | F | 54.05 | 993 | 53,672 | 153,260 | 154.3 K to 153.3 K (-0.64 %) |
| Jun 05 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 350,861 | |
| Jun 05 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 361,181 | |
| Jun 05 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 54.94 | 918 | 50,435 | 109,482 | 110.4 K to 109.5 K (-0.83 %) |
| Jun 05 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 55.59 | 2,700 | 150,093 | 2,852,406 | 2.9 M to 2.9 M (-0.09 %) |
| Jun 05 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 54.93 | 16,200 | 889,866 | 2,855,106 | 2.9 M to 2.9 M (-0.56 %) |
| Jun 05 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,871,306 | 2.9 M to 2.9 M (+0.36 %) |
| Jun 05 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 55.21 | 318 | 17,557 | 110,400 | 110.7 K to 110.4 K (-0.29 %) |
| Jun 05 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 54.58 | 600 | 32,748 | 110,718 | 111.3 K to 110.7 K (-0.54 %) |
| Jun 05 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 54.99 | 10,170 | 559,248 | 2,860,986 | 2.9 M to 2.9 M (-0.35 %) |
| Jun 05 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 54.37 | 8,730 | 474,650 | 2,871,156 | 2.9 M to 2.9 M (-0.30 %) |
| Jun 05 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,879,886 | 2.9 M to 2.9 M (+0.36 %) |
| Jun 05 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Payment of Exercise | F | 54.05 | 2,287 | 123,612 | 2,869,566 | 2.9 M to 2.9 M (-0.08 %) |
| Jun 05 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Option Exercise | M | 19.39 | 6,013 | 116,592 | 32,000 | |
| Jun 05 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Sell | S | 55.16 | 6,013 | 331,677 | 230,311 | 236.3 K to 230.3 K (-2.54 %) |
| Jun 05 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Buy | M | 19.39 | 6,013 | 116,592 | 236,324 | 230.3 K to 236.3 K (+2.61 %) |
| Jun 05 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Payment of Exercise | F | 54.05 | 993 | 53,672 | 230,311 | 231.3 K to 230.3 K (-0.43 %) |
| May 23 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Option Exercise | M | 25.40 | 7,000 | 177,800 | 58,000 | |
| May 23 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Option Exercise | M | 19.39 | 7,987 | 154,868 | 38,013 | |
| May 23 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Sell | S | 55.04 | 14,987 | 824,884 | 231,304 | 246.3 K to 231.3 K (-6.09 %) |
| May 23 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Buy | M | 25.40 | 7,000 | 177,800 | 246,291 | 239.3 K to 246.3 K (+2.93 %) |
| May 23 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Buy | M | 19.39 | 7,987 | 154,868 | 239,291 | 231.3 K to 239.3 K (+3.45 %) |
| May 18 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Option Exercise | M | 9.78 | 1,000 | 9,775 | 7,000 | |
| May 18 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 52.20 | 1,000 | 52,200 | 29,000 | 30 K to 29 K (-3.33 %) |
| May 18 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Buy | M | 9.78 | 1,000 | 9,775 | 30,000 | 29 K to 30 K (+3.45 %) |
| May 18 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 371,501 | |
| May 18 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 381,821 | |
| May 18 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 51.62 | 918 | 47,387 | 111,318 | 112.2 K to 111.3 K (-0.82 %) |
| May 18 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 52.26 | 1,100 | 57,486 | 2,871,853 | 2.9 M to 2.9 M (-0.04 %) |
| May 18 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 51.62 | 17,800 | 918,836 | 2,872,953 | 2.9 M to 2.9 M (-0.62 %) |
| May 18 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,890,753 | 2.9 M to 2.9 M (+0.36 %) |
| May 18 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 52.04 | 918 | 47,773 | 112,236 | 113.2 K to 112.2 K (-0.81 %) |
| May 18 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 52.29 | 9,010 | 471,133 | 2,880,433 | 2.9 M to 2.9 M (-0.31 %) |
| May 18 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 51.71 | 9,890 | 511,412 | 2,889,443 | 2.9 M to 2.9 M (-0.34 %) |
| May 18 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,899,333 | 2.9 M to 2.9 M (+0.36 %) |
| May 11 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Option Exercise | M | 9.78 | 6,000 | 58,650 | 6,000 | |
| May 11 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Sell | S | 47.10 | 6,000 | 282,600 | 127,840 | 133.8 K to 127.8 K (-4.48 %) |
| May 11 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Buy | M | 9.78 | 6,000 | 58,650 | 133,840 | 127.8 K to 133.8 K (+4.69 %) |
| May 04 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 392,141 | |
| May 04 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 402,461 | |
| May 04 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 46.63 | 918 | 42,806 | 113,154 | 114.1 K to 113.2 K (-0.80 %) |
| May 04 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 47.30 | 2,900 | 137,170 | 2,889,013 | 2.9 M to 2.9 M (-0.10 %) |
| May 04 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 46.65 | 16,000 | 746,400 | 2,891,913 | 2.9 M to 2.9 M (-0.55 %) |
| May 04 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,907,913 | 2.9 M to 2.9 M (+0.36 %) |
| May 04 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 47.32 | 918 | 43,440 | 114,072 | 115 K to 114.1 K (-0.80 %) |
| May 04 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 47.33 | 18,900 | 894,537 | 2,897,593 | 2.9 M to 2.9 M (-0.65 %) |
| May 04 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,916,493 | 2.9 M to 2.9 M (+0.36 %) |
| Apr 25 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | M | 2.90 | 32,000 | 92,800 | 0 | |
| Apr 25 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | M | 2.90 | 1,550 | 4,495 | 0 | |
| Apr 25 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Buy | M | 2.90 | 33,550 | 97,295 | 229,884 | 196.3 K to 229.9 K (+17.09 %) |
| Apr 20 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Option Exercise | M | 9.78 | 1,000 | 9,775 | 8,000 | |
| Apr 20 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 47.70 | 1,000 | 47,700 | 29,000 | 30 K to 29 K (-3.33 %) |
| Apr 20 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Buy | M | 9.78 | 1,000 | 9,775 | 30,000 | 29 K to 30 K (+3.45 %) |
| Apr 20 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Option Exercise | M | 2.90 | 4,000 | 11,600 | 0 | |
| Apr 20 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 47.69 | 4,000 | 190,760 | 20,000 | 24 K to 20 K (-16.67 %) |
| Apr 20 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Buy | M | 2.90 | 4,000 | 11,600 | 24,000 | 20 K to 24 K (+20.00 %) |
| Apr 19 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 412,781 | |
| Apr 19 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 423,101 | |
| Apr 19 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 48.60 | 918 | 44,615 | 114,990 | 115.9 K to 115 K (-0.79 %) |
| Apr 19 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 49.22 | 800 | 39,376 | 2,906,173 | 2.9 M to 2.9 M (-0.03 %) |
| Apr 19 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 48.68 | 18,100 | 881,108 | 2,906,973 | 2.9 M to 2.9 M (-0.62 %) |
| Apr 19 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,925,073 | 2.9 M to 2.9 M (+0.35 %) |
| Apr 19 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 48.54 | 918 | 44,560 | 115,908 | 116.8 K to 115.9 K (-0.79 %) |
| Apr 19 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 48.59 | 13,700 | 665,683 | 2,914,753 | 2.9 M to 2.9 M (-0.47 %) |
| Apr 19 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 47.94 | 5,200 | 249,288 | 2,928,453 | 2.9 M to 2.9 M (-0.18 %) |
| Apr 19 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,933,653 | 2.9 M to 2.9 M (+0.35 %) |
| Apr 18 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Sell | S | 48.31 | 3,400 | 164,254 | 152,833 | 156.2 K to 152.8 K (-2.18 %) |
| Apr 18 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Sell | S | 47.39 | 4,100 | 194,299 | 156,233 | 160.3 K to 156.2 K (-2.56 %) |
| Apr 11 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Option Exercise | M | 5.95 | 6,000 | 35,700 | 0 | |
| Apr 11 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Sell | S | 46.80 | 4,600 | 215,280 | 127,840 | 132.4 K to 127.8 K (-3.47 %) |
| Apr 11 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Sell | S | 45.91 | 1,400 | 64,274 | 132,440 | 133.8 K to 132.4 K (-1.05 %) |
| Apr 11 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Buy | M | 5.95 | 6,000 | 35,700 | 133,840 | 127.8 K to 133.8 K (+4.69 %) |
| Apr 11 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Option Exercise | M | 5.95 | 6,000 | 35,700 | 0 | |
| Apr 11 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Sell | S | 46.80 | 4,600 | 215,280 | 127,840 | 132.4 K to 127.8 K (-3.47 %) |
| Apr 11 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Sell | S | 45.91 | 1,400 | 64,274 | 132,440 | 133.8 K to 132.4 K (-1.05 %) |
| Apr 11 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Buy | M | 5.95 | 6,000 | 35,700 | 133,840 | 127.8 K to 133.8 K (+4.69 %) |
| Apr 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 433,421 | |
| Apr 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 443,741 | |
| Apr 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 46.10 | 300 | 13,830 | 116,826 | 117.1 K to 116.8 K (-0.26 %) |
| Apr 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 45.06 | 618 | 27,847 | 117,126 | 117.7 K to 117.1 K (-0.52 %) |
| Apr 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 46.20 | 8,400 | 388,080 | 2,923,333 | 2.9 M to 2.9 M (-0.29 %) |
| Apr 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 45.13 | 10,500 | 473,865 | 2,931,733 | 2.9 M to 2.9 M (-0.36 %) |
| Apr 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,942,233 | 2.9 M to 2.9 M (+0.35 %) |
| Apr 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 46.59 | 218 | 10,157 | 117,744 | 118 K to 117.7 K (-0.18 %) |
| Apr 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 45.36 | 700 | 31,752 | 117,962 | 118.7 K to 118 K (-0.59 %) |
| Apr 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 46.68 | 1,000 | 46,680 | 2,931,913 | 2.9 M to 2.9 M (-0.03 %) |
| Apr 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 45.97 | 7,800 | 358,566 | 2,932,913 | 2.9 M to 2.9 M (-0.27 %) |
| Apr 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 45.16 | 10,100 | 456,116 | 2,940,713 | 3 M to 2.9 M (-0.34 %) |
| Apr 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,950,813 | 2.9 M to 3 M (+0.35 %) |
| Mar 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 9,042 | 32,551 | 454,061 | |
| Mar 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 9,042 | 32,551 | 463,103 | |
| Mar 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 51.13 | 918 | 46,937 | 118,662 | 119.6 K to 118.7 K (-0.77 %) |
| Mar 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 51.63 | 900 | 46,467 | 2,940,493 | 2.9 M to 2.9 M (-0.03 %) |
| Mar 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 51.17 | 18,000 | 921,060 | 2,941,393 | 3 M to 2.9 M (-0.61 %) |
| Mar 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 9,042 | 32,551 | 2,959,393 | 3 M to 3 M (+0.31 %) |
| Mar 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 50.71 | 918 | 46,552 | 119,580 | 120.5 K to 119.6 K (-0.76 %) |
| Mar 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 51.02 | 3,968 | 202,447 | 2,950,351 | 3 M to 3 M (-0.13 %) |
| Mar 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 50.64 | 14,932 | 756,156 | 2,954,319 | 3 M to 3 M (-0.50 %) |
| Mar 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 9,042 | 32,551 | 2,969,251 | 3 M to 3 M (+0.31 %) |
| Mar 16 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Option Exercise | A | 53.75 | 55,000 | 2,956,250 | 55,000 | |
| Mar 16 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Grant | A | 0.00 | 32,000 | 0 | 160,333 | 128.3 K to 160.3 K (+24.94 %) |
| Mar 16 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Sell | S | 53.20 | 9,891 | 526,201 | 128,333 | 138.2 K to 128.3 K (-7.16 %) |
| Mar 16 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Option Exercise | M | 9.78 | 1,000 | 9,775 | 9,000 | |
| Mar 16 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 52.78 | 300 | 15,834 | 29,000 | 29.3 K to 29 K (-1.02 %) |
| Mar 16 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 52.15 | 700 | 36,505 | 29,300 | 30 K to 29.3 K (-2.33 %) |
| Mar 16 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Buy | M | 9.78 | 1,000 | 9,775 | 30,000 | 29 K to 30 K (+3.45 %) |
| Mar 16 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | A | 53.75 | 110,000 | 5,912,500 | 110,000 | |
| Mar 16 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Grant | A | 0.00 | 70,000 | 0 | 2,960,209 | 2.9 M to 3 M (+2.42 %) |
| Mar 16 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Option Exercise | M | 2.90 | 4,000 | 11,600 | 4,000 | |
| Mar 16 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 53.05 | 1,100 | 58,355 | 20,000 | 21.1 K to 20 K (-5.21 %) |